Primary study · included by 1 review

Thromboxane receptor stimulation inhibits adenylate cyclase and reduces cyclic AMP-mediated inhibition of ADP-evoked responses in fura-2-loaded human platelets.

Makarenko 2024 · Sage S O, Heemskerk J W · FEBS letters · 1992

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Makarenko 2024 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Sialadenitis (pooled prevalence)
Radioiodine (I131) therapy · between 6 months and 1 year after RIT
Prevalence 0.20 [0.12, 0.31]3 studies · 527 participantsGRADE not reported
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · between 6 months and 1 year after RIT
Prevalence 0.19 [0.14, 0.25]5 studies · 885 participantsGRADE not reported

1 including review in total.